| 
			 
			For more information please contact:   Investment Banking 
			
			Greg Giebel 
			Managing Director 
			(949) 720-5701 
			
			ggiebel@roth.com
			   
			
			Russ Nudelman 
			Director 
			(310) 445-5872 
			
			
			rnudelman@roth.com 
			      
			Equity Capital Markets 
			
			Aaron Gurewitz 
			Head of Equity 
			Capital Markets 
			(949) 720-5703 
			
			agurewitz@roth.com 
			  
			
			Nazan Akdeniz 
			Senior Vice President 
			(949) 720-5740 
			
			nakdeniz@roth.com 
			  
			
			Lou Ellis 
			Senior Vice President 
			(949) 720-5739 
			
			lellis@roth.com  | 
			
			 
			Transaction Information 
                MediPharm Labs Corp. (TSX: LABS) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, has closed a private placement with an institutional investor, for aggregate gross proceeds of CAD$37,822,500.
  
MediPharm Labs Corp intends to use the proceeds from the offering for general corporate purposes, including building on the launch of its Cannabis 2.0 offerings with new product formats and expanding its product and Active Pharmaceutical Ingredient exports. Additionally, the proceeds will strengthen the Company’s balance sheet as it successfully navigates the economic recession created by the COVID-19 pandemic.
				
  
Roth Capital Partners acted as sole placement agent for the offering.
  
About MediPharm Labs Corp. 
                Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard built clean rooms. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision -dosed cannabis products for its customers. Through its wholesale and white label platforms, they formulate, consumer-test, process, package and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs has completed commercial exports to Australia and is nearing commercialization of its Australian Extraction facility. MediPharm Labs Australia was established in 2017.  For more information, please visit 
			www.medipharmlabs.com. 
			(Source: Company Press Release | 06.08.20)
			
  About ROTH Capital Partners 
			ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and 
			their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, 
			market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and 
			maintains offices throughout the U.S. For more information on ROTH, please visit 
			www.roth.com.  | 
		
		
			| 
			 
			Date of Announcement: 08.20.20 
			The material, information and  facts discussed in this announcement other than the information regarding ROTH Capital Partners, LLC 
			("ROTH") and its affiliates, are from sources believed to be reliable, but are in no way guaranteed to be complete or accurate. This announcement should not be used as a complete analysis of any 
			companies, securities or topics discussed herein. Additional information is available upon request. This is not, however, an 	offer or solicitation of the securities discussed. Any opinions or 
			estimates in this announcement are subject to change without notice. An investment in any security based on this announcement may involve risks and uncertainties that could cause actual results to differ 
			materially from the forward-looking statements. Additionally, such investments may involve a high degree of risk and may not be suitable for all investors. No part of this announcement may be 
			reproduced in any form without the express written permission of ROTH. Copyright 2020.  |